Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELND005 in Alzheimer's Disease
NCT00568776Phase 2Completed
- Sponsor
- OPKO Health
- Start
- Dec 2007
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of scyllo-inositol in Alzheimer's disease (AD), sponsored by OPKO Health. Started Dec 2007; status: completed.
02
Drugs
scyllo-inositol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00568776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568776.